Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.
2.

Retrospective analysis of an experimental high-throughput screening data set by recursive partitioning.

van Rhee AM, Stocker J, Printzenhoff D, Creech C, Wagoner PK, Spear KL.

J Comb Chem. 2001 May-Jun;3(3):267-77.

PMID:
11350250
4.

A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.

Jiang Q, Guo D, Lee BX, Van Rhee AM, Kim YC, Nicholas RA, Schachter JB, Harden TK, Jacobson KA.

Mol Pharmacol. 1997 Sep;52(3):499-507.

5.

Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.

Jiang J, van Rhee AM, Chang L, Patchornik A, Ji XD, Evans P, Melman N, Jacobson KA.

J Med Chem. 1997 Aug 1;40(16):2596-608.

PMID:
9258367
6.
7.

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.

Jiang JL, van Rhee AM, Melman N, Ji XD, Jacobson KA.

J Med Chem. 1996 Nov 8;39(23):4667-75.

PMID:
8917655
8.
9.

Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.

van Rhee AM, Jiang JL, Melman N, Olah ME, Stiles GL, Jacobson KA.

J Med Chem. 1996 Jul 19;39(15):2980-9.

PMID:
8709132
10.

Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.

van Rhee AM, Siddiqi SM, Melman N, Shi D, Padgett WL, Daly JW, Jacobson KA.

J Med Chem. 1996 Jan 19;39(2):398-406.

PMID:
8558508
11.

Molecular Architecture of G Protein-Coupled Receptors.

van Rhee AM, Jacobson KA.

Drug Dev Res. 1996 Jan 1;37(1):1-38.

12.

Modelling the P2Y purinoceptor using rhodopsin as template.

Van Rhee AM, Fischer B, Van Galen PJ, Jacobson KA.

Drug Des Discov. 1995 Nov;13(2):133-54.

13.

Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor.

Kim J, Wess J, van Rhee AM, Schöneberg T, Jacobson KA.

J Biol Chem. 1995 Jun 9;270(23):13987-97.

14.

Molecular probes for muscarinic receptors: functionalized congeners of selective muscarinic antagonists.

Jacobson KA, Fischer B, van Rhee AM.

Life Sci. 1995;56(11-12):823-30. Review.

15.

Novel competitive antagonists for P2 purinoceptors.

van Rhee AM, van der Heijden MP, Beukers MW, IJzerman AP, Soudijn W, Nickel P.

Eur J Pharmacol. 1994 Jun 15;268(1):1-7.

PMID:
7925607
16.

Binding of the radioligand [35S]adenosine 5'-O-(2-thiodiphosphate) and intracellular calcium response in rat liver parenchymal cells.

van Rhee AM, van Winden EC, Nagelkerke JF, de Bont HJ, IJzerman AP, Soudijn W.

Biochem Pharmacol. 1993 Feb 24;45(4):801-7.

PMID:
8452554
17.

Fast atom bombardment/collisional activation mass spectrometry of beta-D-mannosyl-(1----4)-beta-D-N-acetylglucosaminyl (1----N) urea and related compounds.

Heerma W, Dallinga JW, Dorland L, van Rhee AM, van Pelt J, Duran M.

Rapid Commun Mass Spectrom. 1988 May;2(5):95-7.

PMID:
2577844

Supplemental Content

Loading ...
Support Center